Markey Cancer Center Treats 1st Patient in US with New Lung Cancer Therapy

Markey Cancer Center treats 1st patient in US with new lung cancer therapy

LEXINGTON — The University of Kentucky Markey Cancer Center has treated the first patient in the U.S. with a new immunotherapy for small cell lung cancer, offering hope for patients whose cancers have stopped responding to other treatments.

First U.S. Patient Treated With Alveltamig for Small Cell Lung Cancer

A U.S. phase 1 trial of Alveltamig opened at UK Markey, where the first patient with small cell lung cancer was treated in late October.